Lab News
AMP 2021 meeting puts spotlight back on cancer
November 23, 2021 -- Going all-virtual for the second year in a row, the Association for Molecular Pathology (AMP) held its annual event November 15-19. The AMP meeting largely focused on cancer in many of its webinars and on-demand videos, Bruce Carlson of Kalorama Information writes. Read More
Vivera debuts new testing software
November 23, 2021 -- Vivera Pharmaceuticals has launched LabPort, a new testing software application that aims to streamline the diagnostic testing and results reporting process. Read More
Next-generation sequencing can help diagnose T-cell lymphoma
November 19, 2021 -- In hard-to-diagnose cases of T-cell lymphoma, targeted next-generation sequencing should be used as the primary test -- not polymerase chain reaction, according to a report published in Blood Advances on November 16. Read More
Inflammatix lands $12.1M in new BARDA deal
November 19, 2021 -- Molecular diagnostics firm Inflammatix has received a $12.1 million contract extension from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop a test that characterizes infections. Read More
Labcorp to buy Toxikon
November 18, 2021 -- Labcorp has entered a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services. Read More
Cardinal Health launches new lab automation software
November 18, 2021 -- Cardinal Health's WaveMark software for supply automation is now available for implementation in clinical labs across the U.S. Read More
Scientists develop portable SARS-CoV-2 sensor on a chip
November 17, 2021 -- Researchers have constructed a portable, virus-imprinted chip that detects low concentrations of SARS-CoV-2 particles in clinical samples. The chip proved to be almost 27 times more sensitive than polymerase chain reaction (PCR) tests, positioning the technology as a rapid, point-of-care test, according to research published in ACS Sensors on November 11. Read More
Sense raises $65M in series B financing
November 17, 2021 -- Sense Medicine has raised a total of $65 million in series B financing, which the company will use to bring its Veros point-of-care COVID-19 test to the U.S. market. Read More
Prenosis gets $4.3M to develop sepsis test for U.S. military
November 17, 2021 -- The U.S. Department of Defense's Defense Threat Reduction Agency awarded $4.3 million to Prenosis for the development of an early detection sepsis test for military fighting in combat. Read More
PathAI announces results showing reliability of NASH scoring
November 16, 2021 -- PathAI presented results on the concordance among pathologists and two independent panels in scoring nonalcoholic steatohepatitis (NASH) features at the 2021 American Association for the Study of Liver Diseases annual meeting. Read More
Diagnostic Pathology Update (DPU)
December 5-10
Playa Herradura, Puntarenas Costa Rica
American Society of Hematology (ASH) Annual Meeting
December 11-14
Atlanta, Georgia United States
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets